Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

To understand deep learning in the context of genetic disease, you need to understand shallow learning first. Shallow learning relates mutations to diseases by looking for mutations that commonly occur in patients with a disease. It’s a commonly used method.

21 Sep 2015

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Pancreatic cystic neoplasms, or PCNs, are a subset of all pancreatic cysts that are found on the pancreas. PCNs are neoplastic cysts that span a biological spectrum from benign to malignant.

15 Sep 2015

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Services provided to a patient whose medical and/or psychosocial problems require moderate or high-complexity medical decision making during transitions in care from an inpatient setting, partial hospital, observation status in a hospital, or skilled nursing facility to the patient’s community setting.

27 Aug 2015

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Communications professionals often are expected to be experts in all facets of the vast spectrum of communications, from brand, corporate, crisis and digital communications to corporate reputation and channel strategy and everything in between.

From Sanofi 19 Aug 2015

Voice cloning: an interview with Paul Welham, CEO, CereProc

CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.

27 Jul 2015

Multiple sclerosis relapse management: an interview with Gina Remington

MS relapses are typically reflective of new neurological symptoms. However, it can be a worsening of neurologic symptoms that begins after a patient has been stable (generally for about 30 days), but relapses are persistent and consistent changes in symptoms that occur for more than 24 to 48 hours.

26 Jul 2015

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

The spectrum of patients seen today, from pre-term infants to the morbidly obese to the longer living elderly, is wider than ever before and increasingly more challenging with patients often presenting with multiple co-morbidities. This puts a huge strain on healthcare providers who are facing increasing challenges such as cost pressure and staff shortages.

14 Jul 2015

Artemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi

Since 2014, more than 16 million anti-malarial treatments derived from the Sanofi patented process for semi-synthetic artemisinin have been supplied to endemic countries in Africa.

From Sanofi 28 Jun 2015

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

The NHS is under immense pressure not only to continue to deliver improved care but also to change how it is delivering care to meet rising and changing demand with an essentially fixed amount of money and resources - all at the same time. Patience and persistence with good humour are thus vital characteristics to have.

23 Jun 2015

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting.

17 Jun 2015

Point of care measurement of hemoglobin: an interview with Katja Lemburg, EKF Diagnostics

Katja Lemburg discusses the next generation Hemo Control being launched in Europe at EuroMedLab, Paris 21-25th June.

From EKF Diagnostics 7 Jun 2015

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

When people don’t receive the body’s natural signals due to neuropathy, they can unknowingly be exposing their feet to conditions that are known to cause foot ulcers, such as repeated pressure and shear...

4 Jun 2015

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Scarring has been shown to have a significant impact on patients’ lives. As well as the physical burden associated with skin scarring, psychological strains can also negatively affect the quality of life for patients, with the majority (56%) considering themselves to be ‘abnormal’ due to their scars...

3 Jun 2015

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Scientists recognize that 90% of pathogens actually enter the body through the mucosa and secondly, we have evolved a mucosal defense system that can be used to defend against disease...

1 Jun 2015

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

To control reflux symptoms, many people take acid-controlling medications such as Proton Pump Inhibitors, or PPIs. The FDA, however, has issued warnings over the frequent or long-term continued use of PPIs...

18 May 2015

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ICD-10 is the tenth revision to the World Health Organization’s (WHO) International Classification of Diseases. ICD-10, like its predecessor, ICD-9, is based on a set of unique alphanumeric codes to identify known diseases and other health problems...

29 Apr 2015

Medical Insights from Industry

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Voice cloning: an interview with Paul Welham, CEO, CereProc

Multiple sclerosis relapse management: an interview with Gina Remington

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

Artemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

Point of care measurement of hemoglobin: an interview with Katja Lemburg, EKF Diagnostics

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News